Mining Drug–Disease Relationships as a Complement to Medical Genetics-Based Drug Repositioning: Where a Recommendation System Meets Genome-Wide Association Studies

Clinical Pharmacology and Therapeutics

Volumn 97, Issue 5, 2015, Pages 451-454

  Wang, H ^a,b   Gu, Q ^c   Wei, J ^d   Cao, Z ^a   Liu, Q ^a  

^a TONGJI UNIVERSITY   (China)

^b HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DATA MINING; DRUG DEVELOPMENT; DRUG EFFECTS; DRUG REPOSITIONING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC PREDISPOSITION; GENOMICS; HUMAN; MEDICAL GENETICS; PROCEDURES; SYSTEM ANALYSIS;

DATA MINING; DATABASES, GENETIC; DRUG DISCOVERY; DRUG REPOSITIONING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; SYSTEMS INTEGRATION;

EID: 84932137736     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/CPT.82     Document Type: Article

References (5)

1. Hurle, M.R., Yang, L., Xie, Q., Rajpal, D.K., Sanseau, P. & Agarwal. P. Computational drug repositioning: from data to therapeutics. Clin. Pharmacol. Ther. 93, 335–341 (2013).
2. Gottlieb, A., Stein, G.Y. & Ruppin, E. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol. Syst. Biol. 7, 496 (2011).
3. Sanseau, P. et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30, 317–320 (2012).
4. Wang, Z.Y. & Zhang, H.Y. Rational drug repositioning by medical genetics. Nat. Biotechnol. 31, 1080–1082 (2013).
5. Campillos, M. et al. Drug target identification using side-effect similarity. Science 11, 263–266 (2008).